FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3021826369> ?p ?o ?g. }

• W3021826369 endingPage "3022" @default.
• W3021826369 startingPage "2999" @default.
• W3021826369 abstract "High-grade gliomas are still characterized by a poor prognosis, despite recent advances in surgical treatment. Chemotherapy is currently practiced after surgery, but its efficacy is limited by aspecific toxicity on healthy cells, tumour cell chemoresistance, poor selectivity, and especially by the blood-brain barrier (BBB). Thus, despite the large number of potential drug candidates, the choice of effective chemotherapeutics is still limited to few compounds. Malignant gliomas are characterized by high infiltration and neovascularization, and leaky BBB (the so-called blood-brain tumour barrier); surgical resection is often incomplete, leaving residual cells that are able to migrate and proliferate. Nanocarriers can favour delivery of chemotherapeutics to brain tumours owing to different strategies, including chemical stabilization of the drug in the bloodstream; passive targeting (because of the leaky vascularization at the tumour site); inhibition of drug efflux mechanisms in endothelial and cancer cells; and active targeting by exploiting carriers and receptors overexpressed at the blood-brain tumour barrier. Within this concern, a suitable nanomedicine-based therapy for gliomas should not be limited to cytotoxic agents, but also target the most important pathogenetic mechanisms, including cell differentiation pathways and angiogenesis. Moreover, the combinatorial approach of cell therapy plus nanomedicine strategies can open new therapeutical opportunities. The major part of attempted preclinical approaches on animal models involves active targeting with protein ligands, but, despite encouraging results, a few number of nanomedicines reached clinical trials, and most of them include drug-loaded nanocarriers free of targeting ligands, also because of safety and scalability concerns." @default.
• W3021826369 created "2020-05-13" @default.
• W3021826369 creator A5003289983 @default.
• W3021826369 creator A5035816396 @default.
• W3021826369 creator A5063076447 @default.
• W3021826369 creator A5091815659 @default.
• W3021826369 date "2020-04-01" @default.
• W3021826369 modified "2023-10-13" @default.
• W3021826369 title "<p>Overcoming the Blood–Brain Barrier: Successes and Challenges in Developing Nanoparticle-Mediated Drug Delivery Systems for the Treatment of Brain Tumours</p>" @default.
• W3021826369 cites W131042380 @default.
• W3021826369 cites W1470598344 @default.
• W3021826369 cites W1511957901 @default.
• W3021826369 cites W1534592663 @default.
• W3021826369 cites W1547863599 @default.
• W3021826369 cites W1578627837 @default.
• W3021826369 cites W1592180778 @default.
• W3021826369 cites W1721827275 @default.
• W3021826369 cites W1823348626 @default.
• W3021826369 cites W1873198264 @default.
• W3021826369 cites W1901198588 @default.
• W3021826369 cites W194867514 @default.
• W3021826369 cites W1957113176 @default.
• W3021826369 cites W1963525362 @default.
• W3021826369 cites W1965157625 @default.
• W3021826369 cites W1967908989 @default.
• W3021826369 cites W1968482535 @default.
• W3021826369 cites W1968568156 @default.
• W3021826369 cites W1968754817 @default.
• W3021826369 cites W1970482738 @default.
• W3021826369 cites W1971938726 @default.
• W3021826369 cites W1972180606 @default.
• W3021826369 cites W1975976472 @default.
• W3021826369 cites W1980485904 @default.
• W3021826369 cites W1983090757 @default.
• W3021826369 cites W1986129921 @default.
• W3021826369 cites W1986666514 @default.
• W3021826369 cites W1987080692 @default.
• W3021826369 cites W1988318590 @default.
• W3021826369 cites W1990705041 @default.
• W3021826369 cites W1991623686 @default.
• W3021826369 cites W1993451273 @default.
• W3021826369 cites W1996719014 @default.
• W3021826369 cites W1997132649 @default.
• W3021826369 cites W1997362383 @default.
• W3021826369 cites W1999088373 @default.
• W3021826369 cites W2000110198 @default.
• W3021826369 cites W2001257757 @default.
• W3021826369 cites W2001544973 @default.
• W3021826369 cites W2002424169 @default.
• W3021826369 cites W2002727873 @default.
• W3021826369 cites W2005451446 @default.
• W3021826369 cites W2009573953 @default.
• W3021826369 cites W2014485492 @default.
• W3021826369 cites W2015343062 @default.
• W3021826369 cites W2015344488 @default.
• W3021826369 cites W2017331741 @default.
• W3021826369 cites W2018101957 @default.
• W3021826369 cites W2018777412 @default.
• W3021826369 cites W2025370055 @default.
• W3021826369 cites W2026383280 @default.
• W3021826369 cites W2026855866 @default.
• W3021826369 cites W2027561558 @default.
• W3021826369 cites W2028062716 @default.
• W3021826369 cites W2030996838 @default.
• W3021826369 cites W2031812380 @default.
• W3021826369 cites W2031968704 @default.
• W3021826369 cites W2037571189 @default.
• W3021826369 cites W2037984000 @default.
• W3021826369 cites W2038989792 @default.
• W3021826369 cites W2040084528 @default.
• W3021826369 cites W2040594573 @default.
• W3021826369 cites W2043023811 @default.
• W3021826369 cites W2046012377 @default.
• W3021826369 cites W2046826638 @default.
• W3021826369 cites W2050795398 @default.
• W3021826369 cites W2051588629 @default.
• W3021826369 cites W2056461634 @default.
• W3021826369 cites W2058707578 @default.
• W3021826369 cites W2059877047 @default.
• W3021826369 cites W2064325114 @default.
• W3021826369 cites W2066315131 @default.
• W3021826369 cites W2066336297 @default.
• W3021826369 cites W2068091371 @default.
• W3021826369 cites W2074910450 @default.
• W3021826369 cites W2078512011 @default.
• W3021826369 cites W2081215365 @default.
• W3021826369 cites W2084498863 @default.
• W3021826369 cites W2090088751 @default.
• W3021826369 cites W2090627731 @default.
• W3021826369 cites W2093439715 @default.
• W3021826369 cites W2093783077 @default.
• W3021826369 cites W2094364224 @default.
• W3021826369 cites W2101781016 @default.
• W3021826369 cites W2105799345 @default.
• W3021826369 cites W2111631341 @default.
• W3021826369 cites W2112223455 @default.
• W3021826369 cites W2113452176 @default.
• W3021826369 cites W2114438728 @default.

• next